The Role of Inflammation in Treatment-Resistant Depression

1
182

Works Cited

  1. Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, Luisella Bocchio-Chiavetto, Marco Andrea Riva, the MRC ImmunoPsychiatry Consortium, Carmine M. Pariante, Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-? mRNA Levels Accurately Predict Treatment Response in Depressed Patients, International Journal of Neuropsychopharmacology, Volume 19, Issue 10, October 2016, pyw045,
    https://doi.org/10.1093/ijnp/pyw045
  2. Capuron, L., et al. “Association between decreased serum tryptophan
    concentrations and depressive symptoms in cancer patients undergoing
    cytokine therapy.” Molecular Psychiatry, vol. 7, 18 June 2002, pp. 468-72,
    doi:10.1038/sj.mp.4000995. Accessed 19 July 2019.
  3. Capuron, Lucile, et al. “Treatment of cytokine-induced depression Author links open overlay panel.” Brain, Behavior, and Immunity, vol. 16, no. 5, Oct. 2002, pp. 575-80, doi:10.1016/S0889-1591(02)00007-7.
  4. Capuron L, Raison CL, Musselman DL, et al: “Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy”. Am J Psychiatry, vol. 160, 2003, pp. 1342-1345. Doi: 10.1176/appi.ajp.160.7.1342. Accessed 18 July 2019.
  5. Dantzer, Robert, et al. “Inflammation-associated depression: From serotonin to kynurenine.” Psychoneuroendocrinology, vol. 36, no. 3, pp. 426-36, doi:10.1016/j.psyneuen.2010.09.012. Accessed 19 July 2019.
  6. Fourrier, C., Sampson, E., Mills, N.T. et al. Trials (2018) 19: 447. doi: 10.1186/s13063-018-2829-7
  7. Harmer, Catherine J., et al. “How do antidepressants work? New perspectives for refining future treatment approaches.” Lancet Psychiatry, 31 January 2017,pp. 409-18, doi:10.1016/S2215-0366(17)30015-9. Accessed 19 July 2019.
  1. Hugo Juárez Olguín, David Calderón Guzmán, Ernestina Hernández García, and Gerardo Barragán Mejía, “The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 9730467, 13 pages, 2016. https://doi.org/10.1155/2016/9730467.
  2. Jiang, Haiteng, et al. “Hyperactive frontlimbic and frontocentral
    resting-state gamma connectivity in major depressive disorder.” National
    Center for Biotechnology Information, vol. 257, 2 July 2019, doi:10.1016/
    j.jad.2019.06.066. Accessed 19 July 2019. Abstract.
  3. Kiecolt-Glaser, Janice K et al. “Inflammation: depression fans the flames and feasts on the heat.” The American journal of psychiatry vol. 172,11 (2015): 1075-91. doi:10.1176/appi.ajp.2015.15020152
  4. Marieke Wichers, Michael Maes. “The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans”. International Journal of Neuropsychopharmacology. vol. 5, no. 4, December 2002, pp. 375–388. doi: 10.1017/S1461145702003103. Accessed 18 July 2019.
  5. Maydych, Viktoriya. “The Interplay Between Stress, Inflammation, and Emotional Attention: Relevance for Depression.” Frontiers in Neuroscience, 24 Apr.2019, doi:10.3389/fnins.2019.00384. Accessed 18 July 2019.
  6. Mechawar, N., and J. Savitz. “Neuropathology of mood disorders: do we see the stigmata of inflammation?” Translational Psychiatry, doi:10.1038/
    tp.2016.212. Accessed 19 July 2019.
  7. Miller, Andrew H., and Charles L. Raison. “The role of inflammation in
    depression: from evolutionary imperative to modern treatment target.”
    Nature Review Immunology, 29 Dec. 2015, doi:10.1038/nri.2015.5. Accessed 18 July 2019.
  8. Muller, N., et al. “The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.” Molecular Psychiatry, vol.11, 21 Feb. 2006, pp. 680-84, doi:10.1038/sj.mp.4001805. Accessed 19 July 2019.
  1. Newcomer, J W et al. “NMDA receptor function, memory, and brain aging.” Dialogues in clinical neuroscience vol. 2,3 (2000): 219-32. Accessed 18 July 2019.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181613/.
  2. Palazidou, Eleni. “The neurobiology of depression.” British Medical Bulletin, vol. 101, no. 1, Mar. 2012, pp. 127-45, doi:10.1093/bmb/lds004. Accessed 19 July 2019.
  3. Regan, T, Gill, AC, Clohisey, SM, et al. “Effects of anti?inflammatory drugs on the expression of tryptophan?metabolism genes by human macrophages”. J Leukoc Biol. 2018; 103: 681– 692. doi: 10.1002/JLB.3A0617-261R. Accessed 18 July 2019.
  4. Ruhe, H. G., et al. “Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies.”Molecular Psychiatry, vol. 12, pp. 331-59, doi:10.1038/sj.mp.4001949. Accessed 19 July 2019.
  5. Smith, R. S. “The macrophage theory of depression.” Medical Hypotheses, vol. 35, no. 4, Aug. 1991, doi:10.1016/0306-9877(91)90272-Z.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here